ENTRY       D12130            Mixture   Drug
NAME        Drospirenone, ethinyl estradiol and levomefolate calcium;
            Beyaz (TN);
            Safyral (TN);
            Tydemy (TN)
PRODUCT     BEYAZ (Bayer HealthCare Pharmaceuticals)
            DROSPIRENONE/ETHINYL ESTRADIOL/LEVOMEFOLATE CALCIUM AND LEVOMEFOLATE CALCIUM (Sandoz)
            SAFYRAL (Bayer HealthCare Pharmaceuticals)
  GENERIC   DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM AND LEVOMEFOLATE CALCIUM (Lupin Pharmaceuticals)
            DROSPIRENONE/ETHINYL ESTRADIOL/LEVOMEFOLATE CALCIUM AND LEVOMEFOLATE CALCIUM (Sandoz)
            TYDEMY (Lupin Pharmaceuticals)
COMPONENT   Drospirenone [DR:D03917], Ethinyl estradiol [DR:D00554], Levomefolate calcium [DR:D09354]
CLASS       Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Product: D12130<US>
EFFICACY    Contraceptive, Menstruation disorder agent
COMMENT     Drospirenone is a substrate of CYP3A4.
METABOLISM  Enzyme: CYP3A4 [HSA:1576]
INTERACTION  
BRITE       USP drug classification [BR:br08302]
             Contraceptives
              Oral Contraceptives Combinations
               Drospirenone/ Ethinyl Estradiol/ Levomefolate Calcium
                D12130  Drospirenone, ethinyl estradiol and levomefolate calcium
            Drug groups [BR:br08330]
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D12130  Drospirenone, ethinyl estradiol and levomefolate calcium
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D12130
///
